Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Jackson

Showing results (181-190 of 251) with videos related to

Pageof 26
Sort By:
The Journal of Biological Chemistry|October 16, 2003
Unique mechanism of action of the thiourea drug isoxyl on Mycobacterium tuberculosisBenjawan Phetsuksiri, Mary Jackson, Hataichanok Scherman, et al.
Frontiers in Microbiology|October 9, 2018
Optimization and Lead Selection of Benzothiazole Amide Analogs Toward a Novel Antimycobacterial AgentMary A De Groote, Thale C Jarvis, Christina Wong, et al.
The Journal of Biological Chemistry|April 29, 2026
Essential role of MptB in the biosynthesis of phosphatidylinositol mannosides, lipomannan and lipoarabinomannan in mycobacteriaMichal Šarkan, Martin Forbak, Chelsea M Brown, et al.
ACS Infectious Diseases|April 22, 2015
Covalent modification of the <i>Mycobacterium tuberculosis</i> FAS-II dehydratase by Isoxyl and ThiacetazoneAnna E Grzegorzewicz, Nathalie Eynard, Annaïk Quémard, et al.
ACS Infectious Diseases|October 3, 2023
Discovery, Synthesis, and Optimization of 1,2,4-Triazolyl Pyridines Targeting <i>Mycobacterium tuberculosis</i>Tomayo Berida, Samuel R McKee, Shamba Chatterjee, et al.
Bioorganic & Medicinal Chemistry|March 19, 2013
Design, synthesis and anti-tuberculosis activity of 1-adamantyl-3-heteroaryl ureas with improved in vitro pharmacokinetic propertiesE Jeffrey North, Michael S Scherman, David F Bruhn, et al.
The Journal of Emergency Medicine|October 3, 2020
Preliminary Assessment of a Telehealth Approach to Evaluating, Treating, and Discharging Low-Acuity Patients With Suspected COVID-19David J Carlberg, Rahul Bhat, William O Patterson, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2017
<i>Mycobacterium tuberculosis</i> is protected from NADPH oxidase and LC3-associated phagocytosis by the LCP protein CpsAStefan Köster, Sandeep Upadhyay, Pallavi Chandra, et al.
Scientific Reports|July 6, 2017
HLA-E Presents Glycopeptides from the Mycobacterium tuberculosis Protein MPT32 to Human CD8<sup>+</sup> T cellsMelanie J Harriff, Lisa M Wolfe, Gwendolyn Swarbrick, et al.
European Journal of Medicinal Chemistry|October 22, 2010
Synthesis, biological activity, and evaluation of the mode of action of novel antitubercular benzofurobenzopyrans substituted on A ringAikaterini Termentzi, Inana Khouri, Thomas Gaslonde, et al.
Pageof 26

Showing results (181-190 of 251) with videos related to

Sort By:
Pageof 26
The Journal of Biological Chemistry|October 16, 2003
Unique mechanism of action of the thiourea drug isoxyl on Mycobacterium tuberculosisBenjawan Phetsuksiri, Mary Jackson, Hataichanok Scherman, et al.
Frontiers in Microbiology|October 9, 2018
Optimization and Lead Selection of Benzothiazole Amide Analogs Toward a Novel Antimycobacterial AgentMary A De Groote, Thale C Jarvis, Christina Wong, et al.
The Journal of Biological Chemistry|April 29, 2026
Essential role of MptB in the biosynthesis of phosphatidylinositol mannosides, lipomannan and lipoarabinomannan in mycobacteriaMichal Šarkan, Martin Forbak, Chelsea M Brown, et al.
ACS Infectious Diseases|April 22, 2015
Covalent modification of the <i>Mycobacterium tuberculosis</i> FAS-II dehydratase by Isoxyl and ThiacetazoneAnna E Grzegorzewicz, Nathalie Eynard, Annaïk Quémard, et al.
ACS Infectious Diseases|October 3, 2023
Discovery, Synthesis, and Optimization of 1,2,4-Triazolyl Pyridines Targeting <i>Mycobacterium tuberculosis</i>Tomayo Berida, Samuel R McKee, Shamba Chatterjee, et al.
Bioorganic & Medicinal Chemistry|March 19, 2013
Design, synthesis and anti-tuberculosis activity of 1-adamantyl-3-heteroaryl ureas with improved in vitro pharmacokinetic propertiesE Jeffrey North, Michael S Scherman, David F Bruhn, et al.
The Journal of Emergency Medicine|October 3, 2020
Preliminary Assessment of a Telehealth Approach to Evaluating, Treating, and Discharging Low-Acuity Patients With Suspected COVID-19David J Carlberg, Rahul Bhat, William O Patterson, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2017
<i>Mycobacterium tuberculosis</i> is protected from NADPH oxidase and LC3-associated phagocytosis by the LCP protein CpsAStefan Köster, Sandeep Upadhyay, Pallavi Chandra, et al.
Scientific Reports|July 6, 2017
HLA-E Presents Glycopeptides from the Mycobacterium tuberculosis Protein MPT32 to Human CD8<sup>+</sup> T cellsMelanie J Harriff, Lisa M Wolfe, Gwendolyn Swarbrick, et al.
European Journal of Medicinal Chemistry|October 22, 2010
Synthesis, biological activity, and evaluation of the mode of action of novel antitubercular benzofurobenzopyrans substituted on A ringAikaterini Termentzi, Inana Khouri, Thomas Gaslonde, et al.
Pageof 26